Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CEL SCI CORPCVM · Entity 7495 | Chief Scientific Officer | September 30, 2026 | October 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CEL SCI CORP
Report date September 30, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,483 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 1,165 · Balance 10,483 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 1, 2026 16:51 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,165 | $2.06 | $2,399.90 |
DisclosureSEC source: 0001238028-26-000005 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,483 Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:27 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 250,000 | $0.01 Strike: $1.49 | $2,500.00 |
DisclosureSEC source: 0001238028-26-000004 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,625 Underlying: Common Stock · 250,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 12:40 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,307 | $1.04 | $2,399.28 |
DisclosureSEC source: 0001238028-26-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,318 Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 11:08 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 747 | $3.21 | $2,397.87 |
DisclosureSEC source: 0001238028-26-000002 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,011 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:30 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 456 | $5.26 | $2,398.56 |
DisclosureSEC source: 0001238028-26-000001 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,264 Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:01 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 260 | $9.20 | $2,392.00 |
DisclosureSEC source: 0001238028-25-000002 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,808 Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 21:05 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 15,000 | $0.01 Strike: $8.20 | $150.00 |
DisclosureSEC source: 0001236030-25-000011 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,622 Underlying: Common Stock · 15,000 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 13:29 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,048 | $2.29 | $2,399.92 |
DisclosureSEC source: 0001236030-25-000006 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,548 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 13:51 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 10,416 | $0.23 | $2,399.85 |
DisclosureSEC source: 0001236030-25-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,013 Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 19:18 UTC | CEL SCI CORP cvm · Entity 7495 | GrantCommon Stock | 6,001 | $0.40 | $2,400.40 |
DisclosureSEC source: 0001236215-25-000002 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,597 Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 13:13 UTC | CEL SCI CORP cvm · Entity 7495 | GrantCommon Stock | 2,264 | $1.06 | $2,399.84 |
DisclosureSEC source: 0001236215-24-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,596 Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 13:16 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,068 | $1.16 | $2,398.88 |
DisclosureSEC source: 0001236030-24-000018 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,332 Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 21:16 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 182,000 | $0.01 Strike: $1.50 | $1,820.00 |
DisclosureSEC source: 0001236030-24-000009 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,998,646 Underlying: Common Stock · 182,000 shares Expires 2034-04-18 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 13:13 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,256 | $1.91 | $2,398.96 |
DisclosureSEC source: 0001236030-24-000006 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,264 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 14:06 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 882 | $2.72 | $2,399.04 |
DisclosureSEC source: 0001236030-24-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,008 Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 14:43 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,920 | $1.25 | $2,400.00 |
DisclosureSEC source: 0001236030-23-000017 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,126 Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:37 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 182,000 | $0.01 Strike: $1.36 | $1,820.00 |
DisclosureSEC source: 0001236030-23-000009 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,819,046 Underlying: Common Stock · 182,000 shares Expires 2033-08-07 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 13:27 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 995 | $2.41 | $2,397.95 |
DisclosureSEC source: 0001236030-23-000006 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,206 Read SEC document |
| March 31, 2023 Filed Apr 6, 2023 20:22 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,034 | $2.32 | $2,398.88 |
DisclosureSEC source: 0001236030-23-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,211 Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 14:52 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,021 | $2.35 | $2,399.35 |
DisclosureSEC source: 0001236215-23-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,177 Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 11:21 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 776 | $3.09 | $2,397.84 |
DisclosureSEC source: 0001236215-22-000007 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,156 Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 13:20 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 533 | $4.50 | $2,398.50 |
DisclosureSEC source: 0001236215-22-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,380 Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 21:19 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 182,000 | $0.01 Strike: $3.35 | $1,820.00 |
DisclosureSEC source: 0001236030-22-000011 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,644,246 Underlying: Common Stock · 182,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| March 31, 2022 Filed Mar 31, 2022 20:54 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 610 | $3.93 | $2,397.30 |
DisclosureSEC source: 0001236030-22-000007 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,847 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 15:11 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 338 | $7.10 | $2,399.80 |
DisclosureSEC source: 0001236030-22-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,237 Read SEC document |
| November 19, 2021 Filed Nov 29, 2021 14:26 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 50,000 | $0.01 Strike: $10.48 | $500.00 |
DisclosureSEC source: 0001236215-21-000013 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,446 Underlying: Common Stock · 50,000 shares Expires 2031-11-18 F1 · derivative.exercise_date: Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:24 UTC | CEL SCI CORP CVM · Entity 7495 | SaleCommon Stock | 15,000 | $11.25 | $168,750.00 |
DisclosureSEC source: 0001236030-21-000007 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,899 F1 · shares: These shares were sold to pay the taxes due as a result of the milestone reached and subsequent vesting of restricted shares of common stock issued from the 2014 Incentive Stock Bonus Plan. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 13:11 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 218 | $10.99 | $2,395.82 |
DisclosureSEC source: 0001236030-21-000005 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,899 Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 13:08 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 276 | $8.68 | $2,395.68 |
DisclosureSEC source: 0001282304-21-000007 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,681 Read SEC document |
| May 14, 2021 Filed May 17, 2021 21:18 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 318,000 | $0.01 Strike: $20.61 | $3,180.00 |
DisclosureSEC source: 0001236215-21-000005 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,446 Underlying: Common Stock · 318,000 shares Expires 2031-05-13 F1 · derivative.exercise_date: Each option entitles the holder to purchase one share of the Company's common stock at a price of $20.61 per share. The stock options vest 100% upon either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia, or (b) if the closing price of the Company's common stock exceeds $42.00 for one trading day. None of the options will be exercisable before May 13, 2022. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 14:09 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 157 | $15.21 | $2,387.97 |
DisclosureSEC source: 0001646989-21-000004 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,405 Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 14:08 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 205 | $11.66 | $2,390.30 |
DisclosureSEC source: 0001236031-21-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,248 Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 13:37 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 188 | $12.75 | $2,397.00 |
DisclosureSEC source: 0001236031-20-000030 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,043 Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 14:36 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 160 | $14.92 | $2,387.20 |
DisclosureSEC source: 0001236031-20-000026 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,855 Read SEC document |
| April 20, 2020 Filed Apr 20, 2020 20:49 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 288,000 | $0.01 Strike: $10.93 | $2,880.00 |
DisclosureSEC source: 0001236031-20-000018 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,646 Underlying: Common Stock · 288,000 shares Expires 2030-04-19 F1 · derivative.exercise_date: These stock options are performance based. Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.93 per share. The stock options vest upon the achievement of the following performance goals: i) 25% of the options will vest when the closing price of the Company's common stock exceeds $20.00 for ten consecutive trading days; ii) 50% of the options will vest when the closing price of the Company's common stock exceeds $25.00 for ten consecutive trading days; iii) 75% of the options will vest when the closing price of the Company's common stock exceeds $30.00 for ten consecutive trading days; and iv) 100% of the options will vest when either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia or (b) the closing price of the Company's common stock exceeds $40.00 for ten consecutive trading days. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 13:09 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 207 | $11.54 | $2,388.78 |
DisclosureSEC source: 0001236031-20-000014 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,695 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 15:33 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 262 | $9.15 | $2,397.30 |
DisclosureSEC source: 0001236031-20-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,488 Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 20:41 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 268 | $8.94 | $2,395.92 |
DisclosureSEC source: 0001236031-19-000029 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,226 Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:43 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 382,712 | $0.01 Strike: $5.65 | $3,827.12 |
DisclosureSEC source: 0001236031-19-000009 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822,209 Underlying: Common Stock · 382,712 shares Expires 2029-04-10 F1 · shares: Part of the options were awarded in recognition of the salary that has been deferred over an approximate 12 month period and not paid in cash. These options awarded are equal to 0.25 option for every dollar deferred. F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 15:51 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 677 | $3.54 | $2,396.58 |
DisclosureSEC source: 0001236031-19-000004 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,672 Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 22:07 UTC | CEL SCI CORP cvm · Entity 7495 | GrantCommon Stock | 836 | $2.87 | $2,399.32 |
DisclosureSEC source: 0001236215-19-000004 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,995 Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 14:40 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 592 | $4.05 | $2,397.60 |
DisclosureSEC source: 0001236031-18-000040 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,159 Read SEC document |
| September 21, 2018 Filed Sep 21, 2018 18:12 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 100,000 | $0.01 Strike: $3.55 | $1,000.00 |
DisclosureSEC source: 0001236031-18-000037 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,497 Underlying: Common Stock · 100,000 shares Expires 2028-09-20 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 29, 2018 Filed Jul 2, 2018 15:01 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,608 | $0.92 | $2,399.36 |
DisclosureSEC source: 0001236031-18-000030 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,567 Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:28 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 180,000 | $0.01 Strike: $2.45 | $1,800.00 |
DisclosureSEC source: 0001236031-18-000017 · primary_doc.xml · derivative · entry 2 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,497 Underlying: Common Stock · 180,000 shares Expires 2028-04-30 F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:28 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 13,934 | $0.01 Strike: $2.45 | $139.34 |
DisclosureSEC source: 0001236031-18-000017 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,497 Underlying: Common Stock · 13,934 shares Expires 2028-04-30 F1 · shares: The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred. F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 13:57 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,702 | $1.41 | $2,399.82 |
DisclosureSEC source: 0001236031-18-000011 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,959 Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 21:47 UTC | CEL SCI CORP CVM · Entity 7495 | SaleCommon Stock | 6,441 | $2.06 | $13,268.46 |
DisclosureSEC source: 0001236031-18-000008 · primary_doc.xml · nonDerivative · entry 2 TALOR EYAL · CIK 0001238028 · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,257 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| January 17, 2018 Filed Jan 22, 2018 21:47 UTC | CEL SCI CORP CVM · Entity 7495 | SaleCommon Stock | 1,751 | $2.06 | $3,607.06 |
DisclosureSEC source: 0001236031-18-000008 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,698 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:05 UTC | CEL SCI CORP CVM · Entity 7495 | SaleCommon Stock | 1,707 | $2.15 | $3,670.05 |
DisclosureSEC source: 0001236031-18-000007 · primary_doc.xml · nonDerivative · entry 2 TALOR EYAL · CIK 0001238028 · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,449 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.